[go: up one dir, main page]

BjoÈrksteÂn, 2002 - Google Patents

6: Does infection in early life protect against or cause asthma?

BjoÈrksteÂn, 2002

Document ID
10044671263408586458
Author
BjoÈrksteÂn B
Publication year
Publication venue
Asthma: Critical Debates

External Links

Snippet

The development and clinical manifestations of asthma are both influenced by environmental factors. Micro-organisms seem to be particularly important in this respect. It is very well established in the clinic that infections may cause bronchial obstruction and trigger …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18

Similar Documents

Publication Publication Date Title
Björkstén The intrauterine and postnatal environments
Strannegard et al. The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder?
Mine et al. Recent advances in the understanding of egg allergens: basic, industrial, and clinical perspectives
Lodinová-Zádníková et al. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years)
US7172756B2 (en) Methods of promoting tolerogenic immune responses and compositions therefor
Høst et al. Bovine β‐1actoglobulin in human milk from atopic and non‐atopic mothers. Relationship to maternal intake of homogenized and unhomogenized milk
Matricardi et al. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the hygiene hypothesis?
Warner The early life origins of asthma and related allergic disorders
Olivares et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination
US9707258B2 (en) Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants
US20050180961A1 (en) Probiotics and oral tolerance
Björkstén Environment and infant immunity
Lodinová et al. Serum immunoglobulins and coproantibody formation in infants after artificial intestinal colonization with Escherichia coli 083 and oral lysozyme administration
Bruno et al. Prevention of atopic diseases in high risk babies (long-term follow-up)
Lodinová-Žádníková et al. Prevention of allergy in infants of allergic mothers by probiotic Escherichia coli
Saliganti et al. Consumption of probiotic Lactobacillus rhamnosus (MTCC: 5897) containing fermented milk plays a key role in development of the immune system in newborn mice during the suckling–weaning transition
JPH10309178A (en) Antiallergic agent and fermented food containing Bifidobacterium as active ingredient
del Giudice et al. Probiotics in the atopic march: highlights and new insights
CN103826648A (en) Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
Björksten et al. Perinatal environmental factors influencing the development of allergy.
BjoÈrksteÂn 6: Does infection in early life protect against or cause asthma?
CN1109763A (en) Vaccine Potency Boosters and Potency Amplifying Foods
Björkstén The gastrointestinal flora and the skin–is there a link?
Stanaland Symposium Cont. Therapeutic Measures for Prevention of Allergic Rhinitis/Asthma Development.
Stephens Maturation of the Immune System in Breast-Fed and Bottle-Fed Infants